Lexicon Pharmaceuticals (LXRX) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts LXRX Hot Sheet
Price: $2.18 +6.86%
Revenue Growth %: -78.9%
Financial Fact:
Interest expense: -1.65M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -78.9%
Financial Fact:
Interest expense: -1.65M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q3 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $355 thousand versus the consensus estimate of $320 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Vera Bradley (VRA) Tops Q2 EPS by 10c ; Offers Guidance
- Dave & Buster's Entertainment (PLAY) Misses Q2 EPS by 46c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
